Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,150

Quick answer

1,150 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8101651

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8101647

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8101575

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8101630

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8101794

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8101584

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8101572

    Methods for promoting wound healing and/or reducing scar formation

    Arizona Board of Regents, A Corporate Body Organized Under Arizona Law · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8101745

    Lung-targeted drugs

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8101186

    Peptides that block the binding of IgG to FcRn

    Syntonix Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8101382

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8101380

    Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8101198

    Osteogenic enhancer composition

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8101174

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8101370

    Genes from the 20q13 amplicon and their uses

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8101159

    In vivo methods of identifying compounds which target suppressed cancer cells

    The Board of Regents of the University of Oklahoma · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8106026

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8105805

    High affinity human antibodies to human IL-18 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8106022

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8106017

    Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same

    CAREGEN CO., LTD. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8105607

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8105264

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8105263

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8105262

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8105586

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8105626

    Granules containing acid-unstable chemical in large amount

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8106006

    Modified defensins and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8106027

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8105598

    Human monoclonal antibodies that specifically bind IGF-II

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8108030

    Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles

    The Board of Regents of the University of Texas System · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8106082

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8106160

    N-terminal modified interferon-alpha

    PHARMAESSENTIA CORPORATION · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8106087

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8106131

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 2012029034

    Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents

    AMMENDOLA ALDO [DE] · Granted Thu Feb 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8111019

    Sensing type control circuit for electronic apparatus

    Princeton Technology Corporation · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8110674

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8110594

    Diarylthiohydantoin compounds

    The Regents of the University of California · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8110651

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8110569

    Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use

    The Regents of the University of California · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8110553

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8110564

    Bile acid or bile salt fatty acid conjugates

    Galmed International Limited · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8110585

    Bicyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8110352

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,150 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.